MedPath

Mometix

Brand Name: Mometix

Generic Name: Mometasone Furoate (As monohydrate)

Active
Registration Number

DRP-12065

Dosage Form

Metered-Dose Nasal Spray

Issuance Date

July 31, 2024

Expiry Date

June 6, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength50 mcg/actuation (0.05% w/w)
Packaging26 mL-HPDE bottle with metered-dose spray pump, se spray nasal actuator and cap x 140 actuations (Box of 1's)

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Corticosteroid
A
Application
Initial (Reconstruction)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Mometasone Furoate (As monohydrate)Active
Monograph: mometasone furoate (as monohydrate)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform